HEADER HYDROLASE 23-MAR-10 2X9L TITLE CRYSTAL STRUCTURE OF DEACETYLASE-BOG COMPLEX IN BIOSYNTHESIS PATHWAY TITLE 2 OF TEICOPLANIN. COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PUTATIVE UNCHARACTERIZED PROTEIN TCP14, TEICOPLANIN COMPND 5 PSEUDOAGLYCONE DEACETYLASE ORF2; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: BOG SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ACTINOPLANES TEICHOMYCETICUS; SOURCE 3 ORGANISM_TAXID: 1867; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.C.CHAN,Y.T.HUANG,S.Y.LYU,C.J.HUANG,Y.S.LI,Y.C.LIU,C.C.CHOU, AUTHOR 2 M.D.TSAI,T.L.LI REVDAT 5 13-NOV-24 2X9L 1 HETSYN REVDAT 4 29-JUL-20 2X9L 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 15-JAN-14 2X9L 1 JRNL REMARK VERSN REVDAT 2 25-MAY-11 2X9L 1 JRNL REVDAT 1 09-FEB-11 2X9L 0 JRNL AUTH H.C.CHAN,Y.T.HUANG,S.Y.LYU,C.J.HUANG,Y.S.LI,Y.C.LIU, JRNL AUTH 2 C.C.CHOU,M.D.TSAI,T.L.LI JRNL TITL REGIOSELECTIVE DEACETYLATION BASED ON TEICOPLANIN-COMPLEXED JRNL TITL 2 ORF2 CRYSTAL STRUCTURES. JRNL REF MOL.BIOSYST. V. 7 1224 2011 JRNL REFN ISSN 1742-206X JRNL PMID 21267472 JRNL DOI 10.1039/C0MB00320D REMARK 2 REMARK 2 RESOLUTION. 1.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 3 NUMBER OF REFLECTIONS : 25339 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1258 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.0342 - 3.6000 0.91 2731 136 0.1796 0.2039 REMARK 3 2 3.6000 - 2.8585 0.92 2687 156 0.1794 0.1942 REMARK 3 3 2.8585 - 2.4974 0.93 2709 154 0.1877 0.2141 REMARK 3 4 2.4974 - 2.2692 0.93 2744 147 0.1792 0.2145 REMARK 3 5 2.2692 - 2.1066 0.93 2743 128 0.1739 0.2136 REMARK 3 6 2.1066 - 1.9825 0.94 2742 153 0.1846 0.2523 REMARK 3 7 1.9825 - 1.8832 0.94 2767 128 0.1939 0.2357 REMARK 3 8 1.8832 - 1.8013 0.93 2716 123 0.2087 0.2411 REMARK 3 9 1.8013 - 1.7319 0.78 2242 133 0.2236 0.2918 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 44.87 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01880 REMARK 3 B22 (A**2) : -0.31080 REMARK 3 B33 (A**2) : 0.32960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.39450 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2060 REMARK 3 ANGLE : 1.045 2803 REMARK 3 CHIRALITY : 0.066 308 REMARK 3 PLANARITY : 0.004 372 REMARK 3 DIHEDRAL : 19.327 757 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2X9L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1290043177. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 273 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25339 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 27.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 50.00 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE, RESOLVE REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.01400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 PRO A 2 REMARK 465 HIS A 3 REMARK 465 ASP A 4 REMARK 465 PRO A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 7 REMARK 465 HIS A 112 REMARK 465 VAL A 113 REMARK 465 GLU A 114 REMARK 465 GLY A 115 REMARK 465 ARG A 116 REMARK 465 GLN A 117 REMARK 465 LYS A 118 REMARK 465 LEU A 119 REMARK 465 SER A 239 REMARK 465 GLU A 240 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 18 -17.60 146.93 REMARK 500 PHE A 24 14.43 -142.59 REMARK 500 PHE A 44 55.95 -93.99 REMARK 500 ASP A 97 152.12 -49.44 REMARK 500 ASN A 242 34.66 -144.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2004 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH A2005 DISTANCE = 6.73 ANGSTROMS REMARK 525 HOH A2006 DISTANCE = 7.47 ANGSTROMS REMARK 525 HOH A2008 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH A2010 DISTANCE = 8.20 ANGSTROMS REMARK 525 HOH A2011 DISTANCE = 10.71 ANGSTROMS REMARK 525 HOH A2015 DISTANCE = 7.12 ANGSTROMS REMARK 525 HOH A2016 DISTANCE = 6.90 ANGSTROMS REMARK 525 HOH A2019 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A2029 DISTANCE = 9.18 ANGSTROMS REMARK 525 HOH A2035 DISTANCE = 6.76 ANGSTROMS REMARK 525 HOH A2036 DISTANCE = 10.26 ANGSTROMS REMARK 525 HOH A2048 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH A2057 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH A2069 DISTANCE = 7.47 ANGSTROMS REMARK 525 HOH A2092 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A2093 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH A2099 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH A2108 DISTANCE = 7.52 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A3001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 16 ND1 REMARK 620 2 ASP A 19 OD2 98.7 REMARK 620 3 ASP A 19 OD1 151.5 55.0 REMARK 620 4 HIS A 164 NE2 102.3 94.6 91.6 REMARK 620 5 HOH A2253 O 103.4 100.9 74.9 147.5 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DFM RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF THE ZINC INHIBITED FORM OF TEICOPLANIN REMARK 900 DEACETYLASE ORF2 REMARK 900 RELATED ID: 3DFK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF TEICOPLANIN PSEUDOAGLYCONE DEACETYLASE REMARK 900 ORF2* BOUND TO ONE OF ITS PRODUCTS DECANOIC ACID REMARK 900 RELATED ID: 3DFF RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF TEICOPLANIN PSEUDOAGLYCONE DEACETYLASE REMARK 900 ORF2. REMARK 900 RELATED ID: 2XAD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DEACETYLASE-TEICOPLANIN COMPLEX IN REMARK 900 BIOSYNTHESIS PATHWAY OF TEICOPLANIN DBREF 2X9L A 1 273 UNP Q6ZZJ1 Q6ZZJ1_ACTTI 1 273 SEQRES 1 A 273 MSE PRO HIS ASP PRO GLY ALA THR ARG LEU LEU ALA ILE SEQRES 2 A 273 SER PRO HIS LEU ASP ASP ALA VAL LEU SER PHE GLY ALA SEQRES 3 A 273 GLY LEU ALA GLN ALA ALA GLN ASP GLY ALA ASN VAL LEU SEQRES 4 A 273 VAL TYR THR VAL PHE ALA GLY ALA ALA GLN PRO PRO TYR SEQRES 5 A 273 SER PRO ALA ALA GLN ARG MSE HIS THR ILE TRP GLY LEU SEQRES 6 A 273 ALA PRO ASP ASP ASP ALA VAL LEU TYR ARG ARG LYS GLU SEQRES 7 A 273 ASP ILE ALA ALA LEU ASP HIS LEU ARG VAL ALA HIS ARG SEQRES 8 A 273 HIS GLY ARG PHE LEU ASP SER ILE TYR ARG LYS LEU PRO SEQRES 9 A 273 ASP GLY ARG TRP LEU THR ALA HIS VAL GLU GLY ARG GLN SEQRES 10 A 273 LYS LEU ALA VAL ASN ASP HIS SER PRO ASP SER ASP HIS SEQRES 11 A 273 ASP LEU VAL GLY GLU VAL ALA ASP ASP ILE ARG SER ILE SEQRES 12 A 273 ILE ASP GLU PHE ASP PRO THR LEU VAL VAL THR CYS ALA SEQRES 13 A 273 ALA ILE GLY GLU HIS PRO ASP HIS GLU ALA THR ARG ASP SEQRES 14 A 273 ALA ALA LEU PHE ALA THR HIS GLU LYS ASN VAL PRO VAL SEQRES 15 A 273 ARG LEU TRP GLU ASP LEU PRO TYR ALA VAL PHE LYS SER SEQRES 16 A 273 GLY ALA VAL GLU LEU PRO GLN GLY PHE ARG LEU GLY SER SEQRES 17 A 273 ALA ASP VAL SER SER VAL LYS PRO GLU MSE ARG SER GLN SEQRES 18 A 273 LYS PHE GLN ALA VAL GLU ARG TYR SER SER GLN MSE VAL SEQRES 19 A 273 LEU LEU ASN GLY SER GLU ASN ASN LEU PHE ASP ARG LEU SEQRES 20 A 273 ASP GLU HIS ALA ARG GLN ASN ALA PRO HIS GLY GLY TYR SEQRES 21 A 273 GLY GLU THR THR TRP PRO VAL VAL ARG SER ASP ASP SER MODRES 2X9L MSE A 59 MET SELENOMETHIONINE MODRES 2X9L MSE A 218 MET SELENOMETHIONINE MODRES 2X9L MSE A 233 MET SELENOMETHIONINE HET MSE A 59 8 HET MSE A 218 8 HET MSE A 233 8 HET ZN A3001 1 HET BOG A4001 20 HETNAM MSE SELENOMETHIONINE HETNAM ZN ZINC ION HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 2 ZN ZN 2+ FORMUL 3 BOG C14 H28 O6 FORMUL 4 HOH *253(H2 O) HELIX 1 1 ASP A 18 ASP A 34 1 17 HELIX 2 2 SER A 53 TRP A 63 1 11 HELIX 3 3 ASP A 70 ARG A 87 1 18 HELIX 4 4 ASP A 97 ARG A 101 5 5 HELIX 5 5 SER A 125 ASP A 148 1 24 HELIX 6 6 HIS A 161 LYS A 178 1 18 HELIX 7 7 PRO A 189 PHE A 193 5 5 HELIX 8 8 LYS A 215 ARG A 228 1 14 HELIX 9 9 TYR A 229 SER A 231 5 3 HELIX 10 10 GLN A 232 GLY A 238 1 7 HELIX 11 11 ASN A 242 ALA A 255 1 14 SHEET 1 AA 7 ALA A 89 HIS A 92 0 SHEET 2 AA 7 ASN A 37 THR A 42 1 O VAL A 38 N ALA A 89 SHEET 3 AA 7 ARG A 9 SER A 14 1 O LEU A 10 N LEU A 39 SHEET 4 AA 7 LEU A 151 CYS A 155 1 O LEU A 151 N LEU A 11 SHEET 5 AA 7 VAL A 182 TRP A 185 1 O ARG A 183 N THR A 154 SHEET 6 AA 7 THR A 263 ARG A 269 -1 O TRP A 265 N LEU A 184 SHEET 7 AA 7 ASP A 210 VAL A 211 1 O ASP A 210 N THR A 264 SHEET 1 AB 7 ALA A 89 HIS A 92 0 SHEET 2 AB 7 ASN A 37 THR A 42 1 O VAL A 38 N ALA A 89 SHEET 3 AB 7 ARG A 9 SER A 14 1 O LEU A 10 N LEU A 39 SHEET 4 AB 7 LEU A 151 CYS A 155 1 O LEU A 151 N LEU A 11 SHEET 5 AB 7 VAL A 182 TRP A 185 1 O ARG A 183 N THR A 154 SHEET 6 AB 7 THR A 263 ARG A 269 -1 O TRP A 265 N LEU A 184 SHEET 7 AB 7 PHE A 204 LEU A 206 -1 O ARG A 205 N VAL A 268 SHEET 1 AC 2 ASP A 210 VAL A 211 0 SHEET 2 AC 2 THR A 263 ARG A 269 1 O THR A 264 N ASP A 210 LINK C ARG A 58 N MSE A 59 1555 1555 1.33 LINK C MSE A 59 N HIS A 60 1555 1555 1.33 LINK C GLU A 217 N MSE A 218 1555 1555 1.32 LINK C MSE A 218 N ARG A 219 1555 1555 1.33 LINK C GLN A 232 N MSE A 233 1555 1555 1.33 LINK C MSE A 233 N VAL A 234 1555 1555 1.33 LINK ND1 HIS A 16 ZN ZN A3001 1555 1555 2.17 LINK OD2 ASP A 19 ZN ZN A3001 1555 1555 2.18 LINK OD1 ASP A 19 ZN ZN A3001 1555 1555 2.53 LINK NE2 HIS A 164 ZN ZN A3001 1555 1555 2.21 LINK O HOH A2253 ZN ZN A3001 1555 1555 2.40 CISPEP 1 PRO A 50 PRO A 51 0 2.13 CISPEP 2 LEU A 188 PRO A 189 0 2.29 CRYST1 42.452 64.028 50.342 90.00 99.06 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023556 0.000000 0.003756 0.00000 SCALE2 0.000000 0.015618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020115 0.00000